Maria Fardis - Jun 9, 2022 Form 3 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Director
Signature
/s/ Elizabeth Ryland Waldinger
Stock symbol
CRSP
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
3
Date filed
6/10/2022, 05:33 PM
Next filing
Jun 9, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney